Objective: Our previous studies showed that the pleiotropic cytokine leukaemia inhibitory factor (LIF) inhibits the de novo formation of experimental atherosclerotic lesions. The present study examined whether LIF also inhibits progression of pre-existing atheroma. Methods: Balloon angioplasty was performed on the right carotid arteries of 18 rabbits immediately before placing animals on a cholesterol-enriched diet. After 4 weeks, at which time the intima:media ratio (I:M) was 0.9960.12 (n56), osmotic minipumps containing LIF (n56) or saline control (n56) were inserted into the peritoneal cavity of each of the remaining rabbits for a further 4 weeks. Arteries were then harvested for analysis. Results: Continuous administration of LIF for the final 4 weeks of an 8-week cholesterol-enriched diet completely inhibited lesion progression in injured carotid arteries (I:M 1.0560.16) compared with the saline-treated group at 8 weeks (1.6260.13; P,0.05). Similarly in contralateral uninjured carotid arteries, LIF treatment prevented an increase in I:M from a baseline of 0.1160.01 at 4 weeks to 0.1560.02 at 8 weeks compared with 0.4060.04 for the saline-treated group at 8 weeks (P,0.05). LIF reduced the number of macrophages in the neointima of uninjured arteries, but had no effect on the cellular composition of injured arteries. LIF treatment normalised smooth muscle-dependent vasoreactivity to phenylephrine and sodium nitroprusside in both injured and uninjured arteries. Expression and activity of inducible nitric oxide synthase (iNOS) were up-regulated in response to hypercholesterolemia with levels further increased following endothelial denudation. With LIF treatment, iNOS expression was increased in uninjured arteries but marginally reduced in injured arteries. LIF receptors were expressed in both uninjured and injured arteries, with LIF treatment having no significant effect on expression levels. Conclusion: LIF prevents progression of pre-formed atherosclerotic plaques, affecting lesion size and vascular reactivity. LIF treatment has differential effects within the artery wall, depending on the presence or absence of de-endothelialisation injury.
. Introduction
disease [3] . LIF is essential for embryo implantation, and acts directly or synergistically to stimulate osteoblast / The cytokine leukaemia inhibitory factor (LIF) is a osteoclast activity, release of acute-phase proteins by secreted glycoprotein and member of the interleukin- 6 hepatocytes, differentiation of megakaryocytes into family of cytokines. Originally characterised by virtue of platelets, and regulation of angiogenesis. It also promotes its ability to induce the terminal differentiation and supproliferation of skeletal myoblasts and some haemopoietic press the clonogenicity of myeloid leukaemic cells [1] , LIF cells, inhibits adipocyte lipoprotein lipase activity and is now known to possess a diverse range of biological induces cytokine expression in human monocytes. The activities in a variety of tissue systems [2] . LIF directs regulation of these complex processes is mediated by LIF neurotransmitter choice and neuron survival and is under binding to the specific LIF receptor (LIFR)-a subunit clinical trial as a potential treatment for motor neurone which heterodimerises with the common signal transducing subunit for the IL-6 family of cytokine receptors, gp130 [4] .
Previous studies in our laboratory have demonstrated carotid artery as previously described [8] and immediately that LIF also inhibits the development of experimental placed on a 1% cholesterol diet. At 4 weeks, by which atherosclerosis. Continuous administration of LIF to time lesions with a central core of lipid-laden foam cells cholesterol-fed rabbits reduced plasma cholesterol through and a fibrous cap had developed [9] , six rabbits (group I) up-regulation of liver low density lipoprotein receptors, were sacrificed. This group provided an indication of with aortic fatty streak formation almost entirely inhibited lesion size immediately prior to LIF treatment. [5] [6] [7] . Neointima formation induced by either a silastic Also at 4 weeks, an Alzet osmotic minipump (Model cuff or de-endothelialisation injury (i.e. in the presence or 2ML4) containing saline (group II) or hLIF (group III) absence of an intact endothelium) was also significantly was inserted into the peritoneal cavity of each of the 12 inhibited [8] . Further investigation showed that cuff-inremaining rabbits (6 / group). The pumps deliver 2.5 ml / h, duced neointimal thickening was augmented by treatment with a mean volume of 2.167 ml, and therefore are with L-NAME (an inhibitor of nitric oxide synthase, NOS), potentially active for 36 days. The dose of LIF was 30 suggesting that the inhibitory effect of LIF may, at least mg / kg per day, which from our earlier studies is known to partly, be due to induction of NOS activity in the artery be effective in lowering plasma cholesterol and inhibiting wall.
the development of fatty lesions [6] . At the same time, the While these studies showed that LIF inhibits the de novo cholesterol in the chow of these 12 rabbits was reduced to formation of a neointimal thickening in vessels with no 0.5% as continued consumption of 1% cholesterol can prior atheroma, the more important question clinically is result in liver failure after 3-6 months. This dietary regime whether LIF can inhibit the progression, or induce regresconsistently results in elevation of plasma cholesterol from sion, of established atherosclerotic lesions. The present normal levels of 1.060.01 to 10.860.6 mM after a 4-week study therefore utilised a rabbit model of atherosclerosis to diet, with LIF treatment reducing plasma cholesterol to determine the effect of LIF on pre-existing atheroma. This 7.660.5 mM. After 4 weeks of LIF (or saline) infusion, model combines arterial injury with hypercholesterolemia groups II and III were sacrificed with an overdose of and produces an advanced lesion with a central core of sodium pentobarbitone. lipid-filled macrophages covered by a fibrous cap of Immediately following sacrifice, the carotid arteries proliferated smooth muscle cells (SMC), similar to the (injured right and unmanipulated left) were removed from human lesion [9] . We report here that LIF prevents the rabbits and lengths of |1.5 cm used fresh to determine progression of a pre-formed atherosclerotic plaque, affecttheir reactivity to contractile agonists. The remaining (|2.0 ing lesion size and reactivity to contractile and relaxing cm) lengths of artery were used for histology, immunoagents. We also demonstrate, for the first time, the expreschemistry and NOS assay. For histology and immunosion of LIF receptors (both the specific LIFR-a and gp130) chemistry, artery segments were fixed in 4% paraformalin the artery wall.
dehyde, and then each piece cut into four 5.0-mm segments and embedded in paraffin. A total of 24 male 18-week-old New Zealand White Segments of carotid artery were trimmed of adventitial rabbits weighing |2.5 kg were obtained from commercial connective tissue and cut into 3-mm rings. Three rings colonies. They were caged individually, maintained on a from each carotid artery were suspended on fine stainless 12-h day / night cycle, and fed ad libitum with standard steel wire hooks to a tension of 30 mN in a jacketed organ rabbit chow (with or without 1% cholesterol) and small bath (25 ml) containing Tyrode's solution maintained at quantities of fruit and vegetables.
35 8C and continuously gassed with 95% O / 5% CO . 2 2 After a 1-h equilibration, the rings were contracted with 26 2 .3. Experimental protocol phenylephrine (Sigma, St. Louis, MO; 10 M) to determine contractile function. Following rinse-out of the At time 0, six rabbits were placed on normal rabbit solution, cumulative (0.5 log unit) concentration-response chow (untreated controls). The remaining 18 rabbits were (contraction) curves were determined for either 5-hydroxysubjected to balloon catheter denudation injury of the right tryptamine (Sigma) or phenylephrine. Concentration-re-sponse (relaxation) curves following contraction with 5-by Busse and Mulsch [10] . Frozen tissue segments were 27 hydroxytryptamine (3310 M) were determined for pulverized in a mortar-and-pestle and then disrupted in acetylcholine and sodium nitroprusside (both from Sigma).
ice-cold homogenization buffer (25 mM Tris-HCl pH 7.4, Finally, after washout, the contractile response to KCl (100 1 mM EDTA, 1 mM EGTA) by repeated passages through mM) was determined. For each agonist, the maximum a 25-gauge needle. The homogenate was centrifuged at response (E ) and EC values (i.e. the concentration of 13 000 rpm and the resulting supernatant snap-frozen in max 50
drug that elicited 50% of the maximum response) were small aliquots and stored at 220 8C until required. Protein calculated and data compared between treatment groups.
was estimated by Nano-Orange Protein Assay Kit (Molecular Probes, Eugene, OR). Equal amounts of artery cytosol were added to 40 ml of reaction buffer (25 mM Tris-HCl 2 .5. Histology /morphometric analysis pH 7.4, 3 mM tetrahydropterin (Sigma), 1 mM flavin adenine dinucleotide (Sigma), 1 mM flavin adenine monoFor morphometric analysis, paraffin sections were nucleotide (Sigma), 1 mM NADPH (Sigma) and 0.8 mCi stained with toluidine blue. Images were captured via an 3 [ H]arginine (Amersham, UK)) and incubated at 37 8C for Olympus microscope with a solid state colour video 1 h. The assay was terminated by the addition of 'stop camera linked to a computer and the colour images stored buffer' (50 mM Tris-HCl pH 5.5, 5 mM EDTA). Reacted and analyzed using the Mocha image analysis system samples were applied to equilibrated Dowex AG50X-8 (Jandel Scientific, CA, USA). Arteries were circumscribed resin and transferred to spin cups that were centrifuged at by digital planimetry and the areas within the lumen, 13 000 rpm for 30 s. Following addition of scintillint internal elastic lamina (IEL) and external elastic lamina (Readysafe, Beckman Instruments, CA), eluted (EEL) measured directly. The intimal area (encompassing 3 [ H]citrulline was quantified in a Beckman LS 6000TA the atherosclerotic plaque) was calculated by subtracting counter. the lumen from the IEL area. The size of the plaque was expressed as the area of lesion / intima as a ratio of the total 2 .8. Western blot analysis wall area enclosed by the EEL (I:M, intima:media).
Protein extracts of rabbit carotid arteries were prepared 2 .6. Immunohistochemistry by homogenization in ice-cold lysis buffer (10 mM Hepes, 50 mM NaCl, 0.5 mM sucrose, 1 mM EDTA, 0.05 mM Paraffin sections were dewaxed and brought to water EGTA, 0.05% b-mercaptoethanol, 0.5% Triton X-100, 0.6 before pre-incubation in 0.05 M sodium phosphate, 0.15 M mM spermidine) supplemented with a protease inhibitor sodium chloride, pH 7.2 (phosphate-buffered saline, PBS) cocktail (Sigma) to a final concentration of 0.3% (v / v). containing 1% bovine serum albumin (BSA; Sigma) to Samples were further disrupted by repeated passages block non-specific binding. They were then incubated for 2 through a 25-gauge needle and centrifuged at 13 000 rpm h at room temperature with primary antibodies to smooth for 10 min. The supernatant was collected and stored at muscle actin (HHF35), macrophages (RAM 11) or prolif-220 8C until required. Equal amounts of total protein (60 erating cell nuclear antigen (PCNA; PC10) (all mouse mg), as estimated by Nano-Orange fluorescence, were monoclonal antibodies; Dako, Carpinteria, CA). Antibody separated by electrophoresis under denaturing conditions binding was visualised with biotinylated secondary antion an 8% SDS-polyacrylamide gel [11] . Parallel gels were body (anti-mouse Ig; Silenus, Melbourne, Australia), folstained with Coomassie blue to verify the loading of equal lowed by streptavidin-horse radish peroxidase (Silenus) as amounts of protein. Separated proteins were electroblotted third layer and 3,3-diaminobenzadine (DAB; Sigma) as onto PVDF membrane (Millipore, Bedford, MA) [12] . chromagen; sections were counterstained with haematoxAfter drying, membranes were blocked for 1 h with ylin. The total number of neointimal cells and the number blocking buffer (5% non-fat dried milk powder, 10 mM of macrophages in a full cross-section of artery were Tris-HCl pH 8.0, 150 mM NaCl, 0.05% Tween-20) before determined by visual counting. Three to six cross-sections incubation with monoclonal antibodies to iNOS (Transducwere analysed per artery and the percentage of macrotion Laboratories, Lexington, KY; diluted 1:500), LIFR-a phages calculated. indolyl phosphate, toluidine salt) / NBT (nitro blue tetrazolium chloride) (Boehringer Mannheim, Germany). MemiNOS activity in the cytosolic extracts of carotid arteries branes were scanned by densitometry and semi-quantita-
.9. Statistical analysis
Statistical analyses were performed using the statistical software package 'SIGMA STAT' (Jandel Scientific, CA, USA). I:M ratios were subjected to log transformation and analysed by one-way ANOVA (Student-Newman-Keuls comparison). For results expressed as percentages, data were subjected to arcsin square root transformation [13] before analysis. Cell proliferation indices and reactivity to contracting and relaxing agents were compared by oneway ANOVA followed by the Tukey-Kramer test. Results are expressed as mean6S.E.M. In all statistical analyses, a P value of ,0.05 was considered significant. In order to determine the effect of LIF treatment on perimental groups (9.865.7, 10.763.9 and 8.162.6% for progression of pre-existing atheroma, two different exgroups I, II and III, respectively; Fig. 3b ). perimental lesions were induced in the carotid arteries of
The neointima of injured arteries was much larger than rabbits: a simple fatty streak was developed in the left uninjured contralateral arteries after 4 weeks cholesterol carotid artery in response to a 1% cholesterol diet, and a diet (group I; I:M50.9960.12) (Fig. 1) . SMC were the more complex atherosclerotic lesion was induced in the predominant cell type in these lesions (Fig. 2d9) , but there contralateral right carotid artery by a combination of diet was also considerable macrophage involvement (Fig. 2d) . and denudation injury. After 4 weeks, rabbits in group I There were sometimes a small number of macrophages in were sacrificed in order to establish lesion size immedithe media, possibly as the result of damage to the internal ately prior to commencement of LIF administration. At the elastic lamina. The majority of a-smooth muscle actin same time, the remaining 12 animals were implanted with positive cells were close to the internal elastic lamina, osmotic mini-pumps to deliver either saline (group II) or indicating their recent migration from the media, but there LIF (group III) for the final 4 weeks of cholesterol diet.
were also a small number of cells near the lumen. After 8 After 4 weeks cholesterol diet (group I), fatty streak weeks, lesion size for group II animals (I:M51.6260.13) development in uninjured arteries was relatively modest was significantly higher than that at 4 weeks (P,0.05). with I:M50.1160.01 (Fig. 1 ). Macrophages were promiHowever there was no increase in the total number of cells nent in these lesions (Fig. 2a) with 12.164.1 macrophages within lesions, and the proportion of macrophages was not per cross-section (Fig. 3a) . After 8 weeks (group II) there significantly different (Fig. 3a) , nor was the proliferation was a significant increase in lesion size (I:M50.3960.04; index significantly altered (Fig. 3b ). Macrophages were P,0.05) in the saline-treated animals, due to both the seen throughout the neointima (Fig. 2e ), as were SMC that continued accumulation of macrophages (significantly informed randomly-oriented concentric layers. A layer of creased to 114.9623.2 macrophages per cross-section; P, a-smooth muscle actin-positive cells formed an overlying 0.05) (Figs. 2b and 3a) as well as a marked increase in fibrous cap (Fig. 2e9) . LIF treatment (group III) prevented SMC (Fig. 2b9) . LIF treatment (group III) retarded lesion an increase in lesion size such that the I:M (1.0560.16) progression with I:M50.1560.02 (not significantly differwas not significantly different from that of arteries at 4 ent from that at 4 weeks; Fig. 1 ). Both total cell number weeks (group I). LIF treatment had no effect on cell (129.4629.2 per section) and the number of macrophages proliferation (22.166.2; Fig. 3b ) or cellular composition, (61.4615.5 per section) within lesions was significantly with the proportion of macrophages the same as that in less than that in the saline-treated group at 8 weeks group II (48.462.9 vs. 47.362.8%; Fig. 3a ). However, cell (233.3645.4; P,0.05), although the proportion of macrodensity was higher and there were differences in the phages (42.863.8%) was unaltered (Figs. 2c,c9 and 3a) . distribution of cells within the neointima. The majority of Thus in these lesions, LIF treatment appears to have a macrophages were located close to the lumen of the artery similar effect on both macrophages and SMC, reducing the ( Fig. 2f) , while a-smooth muscle actin positive cells were involvement of both cell types proportionally. Interestingscattered throughout the intima and their orientation was ly, proliferation indices were similar for all three exmore uniformly circumferential (Fig. 2f9) . (Fig. 4c,c9) . LIF treatment normalised the response of injured arteries (E 69.767.5 mN), a value not max significantly different from the control group, but significantly increased compared with the saline-treated group II at 8 weeks (E 42.664.9 mN; P,0.05; Fig. 4c9 ).
max Contractions mediated by 5-hydroxytryptamine were unaltered in cholesterol-fed rabbits, with or without LIF treatment (data not shown).
.3. iNOS expression
Western analysis showed that expression of iNOS protein (as evidenced by a single 130-kDa immunoreactive signal) was 3-fold higher in injured arteries at 4 weeks than in uninjured arteries at the same time-point (not shown). After 8 weeks (group II), iNOS expression in injured arteries was 6-fold higher than in their uninjured counterparts (P,0.05; Fig. 5a ). With LIF treatment, iNOS protein expression in uninjured arteries was 33-fold greater than in the saline-treated group II (P,0.05). However LIF-treatment of injured arteries had no significant effect on iNOS protein levels.
Calcium-independent iNOS activity was evident after 4 significant effect on injured arteries.
.4. LIF receptor expression .2. Carotid artery reactivity
Examination of expression of LIF receptor subunits by A cholesterol-enriched diet for 4 or 8 weeks had no Western analysis showed expression of LIFR-a and gp130 significant effect on the response of carotid arteries to the in both injured and uninjured arteries of cholesterol-fed endothelium-dependent vasodilator, acetylcholine (E rabbits (Fig. 6) . LIF treatment had no significant effect on max 211.562.3 and 215.863.3 mN for groups I and II, the expression of receptor subunits. respectively) compared with that for control arteries (E max 217.862.7 mN) (Fig. 4a) . Injury to the right carotid artery completely abrogated the response to acetylcholine even 4 . Discussion after 8 weeks, consistent with the absence of functional endothelium. LIF treatment did not restore this response Our previous studies showed that continuous infusion of (Fig. 4a9) . In contrast, the maximal vasodilator response to LIF inhibits the formation of fatty streaks and neointimal the NO-donor, sodium nitroprusside, was increased in thickenings / atherosclerotic lesions in a rabbit model injured vessels at 4 weeks (E 219.263.3 mN compared [5, 6, 8] . However, for LIF to be an effective treatment of max with 211.561.4 mN for control arteries) and LIF treathuman disease, it must be able to inhibit the progression of ment maintained this increased response (E 221.962.9 pre-existing atherosclerotic plaque. Importantly, the pres- ent study demonstrates that LIF treatment does indeed cell number within lesions did not change. This suggests prevent the progression of pre-existing atherosclerotic the development of an equilibrium between cell proliferlesions (both fatty streaks and more advanced lesions), ation and apoptosis [18] . With LIF treatment, cells within affecting lesion size and vascular reactivity. It also shows the lesions were more ordered and cell density was higher, for the first time that receptors for LIF are present in the suggesting that LIF may be regulating processes involved artery wall and are up-regulated after injury. The results in matrix remodelling. LIF has been shown to play a role suggest that the effect of LIF is partly mediated by in regulating matrix synthesis and degradation in a number activation of iNOS which is also up-regulated by injury of different cell types. In cardiac fibroblasts LIF reduces and further modulated by LIF administration.
collagen synthesis and metalloprotease activity [19] while LIF treatment of pre-existing lesions for the final 4 in osteoclasts it stimulates metalloprotease MMP-13 activiweeks of an 8-week cholesterol-enriched diet inhibited the ty and the metalloprotease inhibitor, tissue inhibitor of increase in lesion size, with I:M not significantly different metalloproteases-1 (TIMP-1) [20] . LIF has also been from those observed at 4 weeks but significantly less than reported to influence proteoglycan metabolism in chonthe saline-treated group at 8 weeks. LIF reduced the total drocytes [21] . number of cells within 'fatty streak' lesions. In injured In contrast to our earlier studies in which administration arteries, however, lesion progression (measured by inof LIF from the time of injury almost completely inhibited creased I:M) was not associated with an increase in cell the development of a smooth muscle-rich neointima [5] , number. These results are in accordance with previous LIF treatment of pre-existing atheroma had no effect on studies in our laboratory and others which show that after cell proliferation. This dichotomy may be explained by our the initial proliferative response to arterial injury, cell recent in vitro studies which suggest that the timing of LIF numbers within the neointima do not increase but cell administration determines the cellular response [22] . LIF density decreases and lesion development is primarily due signalling in vascular cells occurs via the JAK-STAT, MAPK MAPK to the synthesis and accumulation of matrix proteins such ERK and p38 pathways, which regulate the as collagen [14] [15] [16] (Thomas, unpublished data). Clowes expression of downstream genes that are thought to and co-workers [17] further showed that in regions lacking contribute to the inhibition of VSMC proliferation and endothelium, intimal SMC proliferation persisted for up to neointimal formation. The ability of VSMC to respond to 12 weeks after injury but, as in the present study, the total LIF is abrogated when cells are pre-exposed to mitogens the impaired responses to the endothelium-independent agonists phenylephrine and sodium nitroprusside. This such as interleukin-1b which are released at the time of suggests that LIF may be affecting a common pathway of vascular injury (unpublished data). The inhibition of LIF contraction, or may exert an effect on multiple pathways signalling via a 'cross-talk' mechanism suggests that for that contribute to smooth muscle contraction. However LIF LIF to be effective as an anti-proliferative agent, treatment treatment had no apparent effect on endothelial function must commence before cells are exposed to endogenous which was still impaired 8 weeks after injury, as indicated mitogens. In the present study where LIF treatment did not by the lack of response to acetylcholine. The negative commence until after injury (and thus after exposure to effects of LIF on endothelial cell growth have been mitogen), SMC proliferation was not affected. Clowes and reported in our previous study where we showed that LIF Clowes [23] have shown that SMC in the media commit to inhibited endothelial regrowth following balloon injury [8] . entering the cell cycle within the first 24 h after injury and LIF has also been shown to inhibit endothelial cell if this process is inhibited they do not subsequently proliferation in vitro [29, 30] . proliferate; the result is a reduced SMC mass within the The levels of iNOS protein expression and activity were neointima and a corresponding reduction in lesion size.
up-regulated in response to hypercholesterolemia, with The efficacy of LIF may thus be enhanced by timing levels further increased following endothelial denudation administration to inhibit this initial SMC response.
injury (as described previously [31, 32] ). We previously The impairment of vascular reactivity in response to showed that LIF induces iNOS activity in cultured vascular hypercholesterolemia and mechanical injury is well docu-SMC, while in vivo infusion of the NOS inhibitor Lmented [24] [25] [26] with atherosclerotic lesions exhibiting NAME partially abrogated the action of LIF on neointimal increased sensitivity to vasoconstrictors [27] and impaired formation [8] . In the present study, LIF treatment had
